Male Breast Cancer

We have extensive experience in diagnosing and managing male breast cancer, a rare condition. Our imaging specialists and pathologists, as well as surgical, radiation, and medical oncologists, collaborate to create an individualized treatment plan for you based on the type of breast cancer, the molecular features of the tumor tissue, and how advanced the cancer is. Our doctors are active in clinical trials for men with breast cancer, and you and your doctor can discuss whether enrolling in one is right for you.

Clinical Trials and Research Studies

Phase 2

A randomized phase II trial of adjuvant trastuzumab emtansine (T-DM1) followed by subcutaneous trastuzumab versus paclitaxel in combination with subcutaneous trastuzumab for Stage I HER2-positive breast cancer (ATEMPT 2.0)

Learn More

Phase 3

eMonarcHER: A Randomized Double Blind Placebo-Controlled Phase 3 Study of Abemaciclib plus Standard Adjuvant Endocrine Therapy in Participants with High-Risk Node-Positive HR+ HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy

Learn More

Phase 3

The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): COMPASSHER2 Residual Disease (RD) A Double-Blinded Phase III Randomized Trial of T-DM1 Compared with T-DM1 and Tucatinib

Learn More

Phase 1

An Open-label Multicenter Dose Escalation Phase 1b Study to Assess the Safety and Pharmacokinetics of Subcutaneous Delivery of Amivantamab a Human Bispecific EGFR and cMet Antibody for the Treatment of Subjects with Advanced Non-Small Cell Lung Cancer

Learn More